Reply to A. Addeo and A. Bahl Journal Article

  


Authors: Scher, H. I.; Heller, G.; Molina, A.; Kheoh, T.; De Bono, J. S.
Article Title: Reply to A. Addeo and A. Bahl
Keywords: cancer survival; treatment response; survival rate; overall survival; prednisone; cancer combination chemotherapy; outcome assessment; follow up; letter; biological marker; docetaxel; abiraterone acetate; circulating tumor cell; castration resistant prostate cancer; intermediate risk patient; human; male; priority journal; metastatic castration resistant prostate cancer
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 4
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-02-01
Start Page: 387
End Page: 388
Language: English
DOI: 10.1200/jco.2015.64.6562
PROVIDER: scopus
PUBMED: 26598756
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84955468891&partnerID=40&md5=2bf46c2e7edfa35769b293fd5ba5ff0c
Notes: Letter -- Export Date: 3 March 2016 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Glenn Heller
    399 Heller
  2. Howard Scher
    1130 Scher
Related MSK Work